Dapagliflozin: Cost-effectiveness As an Add-on Therapy to Metformin in the Treatment of Type 2 Diabetes (T2DM) in Argentina and ChileJ. F. Elgart,M. Prestes,L. Gonzalez, S. Asteazaran,E. Aiello,S. Garrido Lecca,A. Alvarez, M. Roberts, P. Cortes Cuadra,J. J. GagliardinoValue in Health（2014）引用 1|浏览10AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
